- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
|---|---|---|---|---|
| Di | Arcutis Biotherapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | |
| 10.06. | Arcutis Biotherapeutics, Inc.: Arcutis Announces New Long-Term Data of Roflumilast Cream 0.15% for the Treatment of Mild to Moderate Atopic Dermatitis (AD) in Adults and Children Down to Age Six Presented at Revolutionizing Alopecia Areata, Vitiligo, and | 67 | GlobeNewswire (Europe) | |
| 05.06. | Arcutis Biotherapeutics, Inc.: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 46 | GlobeNewswire (Europe) | |
| 17.05. | Novavax, Capricor Therapeutics, Arcutis Biotherapeutics among healthcare movers | 18 | Seeking Alpha | |
| 15.05. | Arcutis Biotherapeutics surges 22% on Q1 beats | 4 | Seeking Alpha | |
| 15.05. | Earnings call: Arcutis Biotherapeutics reports strong Q1 2024 growth | 2 | Investing.com | |
| 15.05. | Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q1 2024 Earnings Call Transcript | 3 | Insider Monkey | |
| 15.05. | Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket | 5 | Benzinga.com | |
| 15.05. | US STOCKS Nextracker, Arcutis Biotherapeutics, Nu Holdings | 10 | Reuters | |
| 15.05. | Drugmaker Arcutis jumps on rise in Q1 revenue | 5 | Reuters | |
| 14.05. | Arcutis Biotherapeutics Inc reports results for the quarter ended in March - Earnings Summary | 3 | Reuters | |
| 14.05. | Arcutis Biotherapeutics up after Q1 revenue rises | 2 | Reuters | |
| 14.05. | Arcutis Biotherapeutics Stock Climbs After Blockbuster Q1 Results | 4 | Benzinga.com | |
| 14.05. | Arcutis Biotherapeutics GAAP EPS of -$0.32 beats by $0.41, revenue of $49.56M | 3 | Seeking Alpha | |
| 14.05. | Arcutis Biotherapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | |
| 03.05. | Arcutis Biotherapeutics, Inc.: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 241 | GlobeNewswire (Europe) | |
| 29.04. | Arcutis Biotherapeutics, Inc.: Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 | 3 | GlobeNewswire (USA) | |
| 12.04. | Evaluating Arcutis Biotherapeutics: Insights From 5 Financial Analysts | 11 | Benzinga.com | |
| 10.04. | Arcutis Biotherapeutics, Inc. - 8-K, Current Report | 3 | SEC Filings | |
| 10.04. | Arcutis Biotherapeutics Appoints David Topper To Succeed John Smither As CFO | 2 | RTTNews |
Seite:
1 2 3 4 Weiter >>
67 Nachrichten in den letzten 12 Monaten
Das Unternehmen ARCUTIS BIOTHERAPEUTICS INC kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 8,150 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
